MARCY DEAN: Open Payments
NPI 1265983431 · WINSTON, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$163 in 7 payments from 6 companies in 2025. Trend: 2023 $174 · 2024 $130 · 2025 $163
Food & beverage: $163
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| GlaxoSmithKline, LLC. | 1 | $33 |
| Novo Nordisk Inc | 1 | $24 |
| ABBVIE INC. | 1 | $23 |
| PFIZER INC. | 1 | $17 |
| Alkermes, Inc. | 1 | $16 |
Products named: REXULTI, TRELEGY ELLIPTA, Ozempic, VRAYLAR, NURTEC ODT, ARISTADA.
Industry payments across OR — which companies pay providers there.
